論文

査読有り 最終著者 責任著者 本文へのリンクあり 国際誌
2020年6月18日

Application of Biopsy Samples Used for Helicobacter pylori Urease Test to Predict Epstein-Barr Virus-Associated Cancer.

Microorganisms
ダウンロード
回数 : 198
  • Andy Visi Kartika
  • ,
  • Hisashi Iizasa
  • ,
  • Dan Ding
  • ,
  • Yuichi Kanehiro
  • ,
  • Yoshitsugu Tajima
  • ,
  • Shunsuke Kaji
  • ,
  • Hideo Yanai
  • ,
  • Hironori Yoshiyama

8
6
開始ページ
923
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/microorganisms8060923
出版者・発行元
MDPI AG

Persistent gastric mucosal damage caused by Helicobacter pylori infection is a major risk factor for gastric cancer (GC). The Epstein-Barr virus (EBV) is also associated with GC. Most patients with EBV-associated GC are infected with H. pylori in East Asia. However, very few reports have described where and when both H. pylori and EBV infect the gastric mucosa. To clarify this, old biopsy samples used for the rapid urease test (RUT) were applied to count EBV genomic DNA (gDNA) copies using DNA probe quantitative polymerase chain reaction. DNA extracted from the gastric biopsy samples of 58 patients with atrophic gastritis was used to analyze the correlation between the degree of atrophic gastritis and the copy number of EBV gDNA. EBV was detected in 44 cases (75.9%), with viral copy numbers ranging from 12.6 to 4754.6. A significant correlation was found between patients with more than 900 copies of EBV gDNA and those with a more severe grade of atrophic gastritis (p = 0.041). This study shows that EBV can be detected in RUT samples in a manner that reduces patient burden.

リンク情報
DOI
https://doi.org/10.3390/microorganisms8060923
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32570907
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355529
URL
https://www.mdpi.com/2076-2607/8/6/923/pdf
ID情報
  • DOI : 10.3390/microorganisms8060923
  • eISSN : 2076-2607
  • PubMed ID : 32570907
  • PubMed Central 記事ID : PMC7355529

エクスポート
BibTeX RIS